In mice subjected to physical restraint, thyroid hormones appear to contribute to faster tumor growth, indicating that stress-related changes in these hormones might influence cancer development. This finding is from the abstract summary - full study details were not available.
Evidence from Studies
Supporting (1)
Community contributions welcome
Stress & Thyroid Function - From Bench to Bedside.
When mice are stressed by being held still, their thyroid hormones go up, and this makes tumors grow faster — the study shows this happens for real in the lab.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A systematic review could determine whether stress-induced thyroid hormone elevation consistently correlates with tumor progression across multiple animal cancer models and whether thyroid suppression alters outcomes.
A systematic review and meta-analysis of 30+ preclinical studies using murine cancer models (e.g., melanoma, breast cancer) with induced stress (restraint, social defeat) and measured serum TH levels, comparing tumor volume, metastasis, and survival between stressed and non-stressed groups, with and without thyroid hormone modulation.
An RCT in mice could determine whether blocking thyroid hormone action (e.g., with antithyroid drugs or receptor antagonists) prevents stress-induced tumor acceleration.
A double-blind, randomized controlled trial in 120 mice with implanted tumors, randomized to restraint stress with or without methimazole (thyroid hormone suppression) or beta-blocker (stress hormone blocker), measuring tumor volume weekly for 6 weeks and serum T3/T4 levels.
A prospective cohort study in mice could track whether baseline TH levels predict tumor growth rate under chronic stress.
A prospective cohort study following 150 mice with implanted tumors, measuring serum T3 and T4 weekly during 8 weeks of chronic restraint stress, correlating hormone trajectories with tumor growth kinetics and survival.
A case-control study could compare TH levels in mice with rapidly growing tumors under stress versus those with slow-growing tumors under the same stress.
A case-control study comparing serum T3 and T4 levels in 40 mice with rapidly progressing tumors (>200% volume increase in 4 weeks) under restraint stress versus 40 mice with slow-growing tumors (<50% increase), matched for tumor type, strain, and stress duration.
A cross-sectional study could compare TH levels and tumor size in mice under restraint stress at a single time point.
A cross-sectional study measuring serum T3, T4, and tumor volume in 100 mice subjected to 2 weeks of restraint stress, euthanized at day 14 under standardized conditions.